Pieris Pharmaceuticals (PIRS) Short Interest Ratio & Short Volume → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free PIRS Stock Alerts $11.16 +0.19 (+1.73%) (As of 01:32 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Pieris Pharmaceuticals Short Interest DataCurrent Short Interest12,800 sharesPrevious Short Interest300 sharesChange Vs. Previous Month+4,166.67%Dollar Volume Sold Short$149,888.00Short Interest Ratio0.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares1,320,000 sharesFloat Size1,140,000 sharesShort Percent of Float1.12%Today's Trading Volume2,345 sharesAverage Trading Volume10,738 sharesToday's Volume Vs. Average22% Short Selling Pieris Pharmaceuticals ? Sign up to receive the latest short interest report for Pieris Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPIRS Short Interest Over TimePIRS Days to Cover Over TimePIRS Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Pieris Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202412,800 shares $149,888.00 +4,166.7%1.1%0.9 $11.71 4/15/2024300 shares $4,080.00 -99.8%0.0%0 $13.60 3/31/2024134,100 shares $24,567.12 +222.4%N/A0.2 $0.18 3/15/202441,600 shares $7,030.40 -41.2%N/A0.1 $0.17 2/29/202470,700 shares $11,672.57 +6.8%N/A0.1 $0.17 2/15/202466,200 shares $10,505.94 -69.1%N/A0.1 $0.16 Get the Latest News and Ratings for PIRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pieris Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024214,500 shares $39,661.05 +31.1%N/A0.4 $0.18 1/15/2024163,600 shares $29,268.04 +22.6%N/A0.3 $0.18 12/31/2023133,400 shares $24,278.80 -17.5%N/A0.2 $0.18 12/15/2023161,600 shares $26,680.16 +145.6%N/A0.3 $0.17 11/30/202365,800 shares $13,442.94 -3.1%N/A0.1 $0.20 11/15/202367,900 shares $15,725.64 -63.5%N/A0.1 $0.23 10/31/2023186,100 shares $44,273.19 -26.7%N/A0.1 $0.24 10/15/2023253,900 shares $72,006.04 -55.7%N/A0.1 $0.28 9/30/2023573,500 shares $170,903.00 -5.2%N/A0.2 $0.30 9/15/2023605,200 shares $188,822.40 -57.4%N/A0.2 $0.31 8/31/20231,420,000 shares $481,806.00 +35.2%N/A0.4 $0.34 8/15/20231,050,000 shares $252,420.00 -28.6%N/A0.3 $0.24 7/31/20231,470,000 shares $324,870.00 +293.8%N/A0.5 $0.22 7/15/2023373,300 shares $72,793.50 -84.6%N/A0.1 $0.20 6/30/20232,420,000 shares $400,510.00 +32.2%N/A1.6 $0.17 6/15/20231,830,000 shares $1.63 million -1.1%N/A1.4 $0.89 5/31/20231,850,000 shares $1.57 million +0.5%N/A2.6 $0.85 5/15/20231,840,000 shares $1.59 million -1.1%N/A3 $0.86 4/30/20231,860,000 shares $1.41 million +1.6%N/A5.4 $0.76 4/15/20231,830,000 shares $1.31 million -0.5%N/A6.8 $0.72 3/31/20231,840,000 shares $1.80 million +0.6%2.9%6.4 $0.98 3/15/20231,830,000 shares $2.67 million No Change2.9%5.9 $1.46 2/28/20231,830,000 shares $2.75 million -0.5%2.9%5.6 $1.50 2/15/20231,840,000 shares $2.93 million -32.4%2.9%4.6 $1.59 1/31/20232,720,000 shares $4.35 million +70.0%N/A6.4 $1.60 1/15/20231,600,000 shares $2.40 million +0.6%N/A4.2 $1.50 12/30/20221,590,000 shares $1.65 million -4.2%N/A4.9 $1.04 12/15/20221,660,000 shares $1.63 million +0.6%N/A6.5 $0.98 11/30/20221,650,000 shares $1.61 million No ChangeN/A7.4 $0.98 11/15/20221,650,000 shares $1.61 million +1.9%N/A7.3 $0.98 10/31/20221,620,000 shares $1.80 million +14.1%N/A10 $1.11 10/15/20221,420,000 shares $1.42 million -4.7%2.3%8.4 $1.00 9/30/20221,490,000 shares $1.71 million +8.8%2.4%8 $1.15 9/15/20221,370,000 shares $1.89 million +5.4%2.2%6.8 $1.38This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 8/31/20221,300,000 shares $1.90 million -3.0%2.1%5.7 $1.46 8/15/20221,340,000 shares $2.29 million +9.8%2.1%5.1 $1.71 7/31/20221,220,000 shares $2.15 million +1.7%1.9%3.7 $1.76 7/15/20221,200,000 shares $2.26 million +3.5%1.9%3.3 $1.88 6/30/20221,160,000 shares $2.17 million +6.4%1.9%3.1 $1.87 6/15/20221,090,000 shares $1.80 million +18.0%1.7%2.7 $1.65 5/31/2022923,900 shares $1.64 million +45.3%1.5%2.3 $1.78 5/15/2022635,700 shares $1.09 million -11.8%1.0%1.5 $1.71 4/30/2022720,700 shares $2.02 million +12.6%1.2%1.7 $2.80 4/15/2022640,000 shares $2.01 million -42.9%1.0%1.4 $3.14 3/31/20221,120,000 shares $3.39 million +86.0%1.8%2.1 $3.03 3/15/2022602,200 shares $1.80 million -13.4%1.0%0.8 $2.99 2/28/2022695,100 shares $2.15 million +18.4%1.1%0.8 $3.09 2/15/2022587,100 shares $2.00 million -13.5%1.0%0.7 $3.40 1/31/2022678,500 shares $2.47 million -7.7%1.1%0.8 $3.64 1/15/2022734,900 shares $2.56 million -6.8%1.2%0.8 $3.49 12/31/2021788,700 shares $2.98 million +69.4%1.3%0.9 $3.78 12/15/2021465,500 shares $1.52 million -20.9%0.8%0.5 $3.26 11/30/2021588,800 shares $1.94 million -15.2%1.0%0.6 $3.30 11/15/2021694,000 shares $2.70 million -75.4%1.2%0.6 $3.89 10/29/20212,820,000 shares $12.92 million +75.2%4.7%2.1 $4.58 10/15/20211,610,000 shares $7.26 million +49.1%2.9%1.2 $4.51 9/30/20211,080,000 shares $5.58 million -1.8%1.9%0.7 $5.17 9/15/20211,100,000 shares $6.12 million +10.6%2.0%0.4 $5.56 8/31/2021994,200 shares $5.36 million -9.6%1.8%0.3 $5.39 8/13/20211,100,000 shares $4.22 million -47.6%2.0%0.1 $3.84 7/30/20212,100,000 shares $7.31 million -30.0%3.8%0.2 $3.48 7/15/20213,000,000 shares $10.56 million -11.2%5.8%0.3 $3.52 6/30/20213,380,000 shares $12.95 million -14.4%6.5%0.3 $3.83 6/15/20213,950,000 shares $13.79 million -44.0%7.6%0.4 $3.49 5/28/20217,050,000 shares $24.25 million +173.3%13.5%0.8 $3.44 5/14/20212,580,000 shares $4.82 million -8.5%N/A0.4 $1.87 4/30/20212,820,000 shares $6.23 million +10.6%6.0%4.5 $2.21 4/15/20212,550,000 shares $5.33 million +0.4%5.4%4.4 $2.09 3/31/20212,540,000 shares $6.35 million +8.1%N/A4.9 $2.50 3/15/20212,350,000 shares $6.20 million -6.4%N/A6 $2.64 2/26/20212,510,000 shares $7.03 million +8.2%N/A6.1 $2.80 2/12/20212,320,000 shares $6.80 million +13.2%N/A5.9 $2.93 1/29/20212,050,000 shares $5.23 million -1.0%N/A6 $2.55 1/15/20212,070,000 shares $5.78 million -3.7%N/A5.8 $2.79 12/31/20202,150,000 shares $5.70 million +9.7%N/A6.3 $2.65 12/15/20201,960,000 shares $5.23 million +5.4%N/A5.3 $2.67 11/30/20201,860,000 shares $5.49 million -7.9%N/A4.8 $2.95 11/15/20202,020,000 shares $5.51 million -8.2%N/A5.4 $2.73 10/30/20202,200,000 shares $5.37 million +26.4%N/A5.4 $2.44 10/15/20201,740,000 shares $4.15 million -3.9%N/A3.8 $2.39 9/30/20201,810,000 shares $3.75 million -1.1%N/A3.6 $2.07 9/15/20201,830,000 shares $5.38 million -2.7%N/A3.6 $2.94 8/31/20201,880,000 shares $5.38 million -1.6%N/A4 $2.86 8/14/20201,910,000 shares $5.83 million -1.0%N/A3.8 $3.05This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 7/31/20201,930,000 shares $4.96 million -16.8%N/A3.9 $2.57 7/15/20202,320,000 shares $6.80 million +2.7%N/A5.7 $2.93 6/30/20202,260,000 shares $7.21 million +16.5%N/A6.3 $3.19 6/15/20201,940,000 shares $5.90 million -4.9%N/A5.1 $3.04 5/29/20202,040,000 shares $7.34 million +4.1%N/A4.4 $3.60 5/15/20201,960,000 shares $5.47 million +9.5%N/A4.3 $2.79 4/30/20201,790,000 shares $4.74 million +1.1%N/A4 $2.65 4/15/20201,770,000 shares $4.57 million +0.6%N/A3.3 $2.58 3/31/20201,760,000 shares $5.00 million +25.2%N/A3.2 $2.84 3/13/20201,405,300 shares $3.56 million -5.7%N/A2.9 $2.53 2/28/20201,490,000 shares $3.11 million +8.8%N/A3 $2.09 2/14/20201,370,000 shares $3.52 million -16.0%2.9%2.7 $2.57 1/31/20201,630,000 shares $5.56 million +38.1%3.4%2.8 $3.41 1/15/20201,180,000 shares $4.72 million -32.6%2.4%2.1 $4.00 12/31/20191,750,000 shares $5.65 million -6.9%3.6%3.3 $3.23 PIRS Short Interest - Frequently Asked Questions What is Pieris Pharmaceuticals' current short interest? Short interest is the volume of Pieris Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 12,800 shares of PIRS short. 1.12% of Pieris Pharmaceuticals' shares are currently sold short. Learn More on Pieris Pharmaceuticals' current short interest. What is a good short interest ratio for Pieris Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PIRS shares currently have a short interest ratio of 1.0. Learn More on Pieris Pharmaceuticals's short interest ratio. What is a good short interest percentage for Pieris Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.12% of Pieris Pharmaceuticals' floating shares are currently sold short. Is Pieris Pharmaceuticals' short interest increasing or decreasing? Pieris Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 12,800 shares, an increase of 4,166.7% from the previous total of 300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Pieris Pharmaceuticals' float size? Pieris Pharmaceuticals currently has issued a total of 1,320,000 shares. Some of Pieris Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pieris Pharmaceuticals currently has a public float of 1,140,000 shares. How does Pieris Pharmaceuticals' short interest compare to its competitors? 1.12% of Pieris Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Pieris Pharmaceuticals: FSD Pharma Inc. (1.00%), RedHill Biopharma Ltd. (2.38%), Edesa Biotech, Inc. (0.69%), Purple Biotech Ltd (1.18%), Kiora Pharmaceuticals, Inc. (0.56%), Eterna Therapeutics Inc. (1.15%), Imunon, Inc. (3.95%), Tonix Pharmaceuticals Holding Corp. (1.89%), NeuroSense Therapeutics Ltd. (0.16%), Akari Therapeutics, Plc (0.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Pieris Pharmaceuticals stock? Short selling PIRS is an investing strategy that aims to generate trading profit from Pieris Pharmaceuticals as its price is falling. PIRS shares are trading down $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pieris Pharmaceuticals? A short squeeze for Pieris Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PIRS, which in turn drives the price of the stock up even further. How often is Pieris Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PIRS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: HUGE Short Squeeze RDHL Short Squeeze EDSA Short Squeeze PPBT Short Squeeze KPRX Short Squeeze ERNA Short Squeeze IMNN Short Squeeze TNXP Short Squeeze NRSN Short Squeeze AKTX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PIRS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDoes this make you sick?Allegiance GoldThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace